Publications by authors named "Irina Mirkina"

18Publications

Phenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing ErbB4, EPO-R and NGF-R.

PLoS One 2014 29;9(1):e84417. Epub 2014 Jan 29.

Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria ; Division of Hematology & Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

View Article and Find Full Text PDF
September 2014

Evidence for PI3K-dependent CXCR3 agonist-induced degranulation of human cord blood-derived mast cells.

Mol Immunol 2010 Aug 2;47(14):2367-77. Epub 2010 Jun 2.

Inflammatory Cell Biology Laboratory, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath BA2 7AY, UK.

View Article and Find Full Text PDF
August 2010

H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells.

Exp Hematol 2010 Oct 1;38(10):896-907. Epub 2010 Jun 1.

Department for Companion Animals and Horses, Clinic for Internal Medicine and Infectious Diseases, University of Veterinary Medicine Vienna, Vienna, Austria.

View Article and Find Full Text PDF
October 2010

Neoplastic stem cells: current concepts and clinical perspectives.

Crit Rev Oncol Hematol 2010 Nov 25;76(2):79-98. Epub 2010 Feb 25.

Bone Marrow Transplantation Unit, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

View Article and Find Full Text PDF
November 2010

Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE Omalizumab.

Immunol Lett 2007 Apr 1;109(2):120-8. Epub 2007 Mar 1.

Novartis Institutes for BioMedical Research, Brunnerstrasse 59, A-1235 Vienna, Austria.

View Article and Find Full Text PDF
April 2007